Investors in Celldex Therapeutics, Inc. (CLDX - Get Report) saw new options begin trading this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CLDX options chain for the new November 17th contracts and identified the following call contract of particular interest.The call contract at the $6.00 strike price has a current bid of 10 cents. If an investor was to purchase shares of CLDX stock at the current price level of $3.27/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $6.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 86.54% if the stock gets called away at the November 17th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CLDX shares really soar, which is why looking at the trailing twelve month trading history for Celldex Therapeutics, Inc., as well as studying the business fundamentals becomes important. Below is a chart showing CLDX's trailing twelve month trading history, with the $6.00 strike highlighted in red: Considering the fact that the $6.00 strike represents an approximate 83% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 74%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 3.06% boost of extra return to the investor, or 4.63% annualized, which we refer to as the YieldBoost. The implied volatility in the call contract example above is 154%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $3.27) to be 66%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Ear to the Ground on UTX-Raytheon: What Needs to Happen for the Deal to Close
Shareholders are skittish about this deal, one analyst said. See why they shouldn't be.
AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential
AbbVie's deal for Allergan will give it a new revenue stream in Botox, helping offset potential lower revenue from arthritis drug Humira, which is losing patent protection.
Care.com Shares Slump After Chief Financial Officer Resigns
Care.com's finance chief resigns a few months after a Wall Street Journal report that many day-care centers listed on the company's site were unlicensed.
Dow Ends Down on Mixed Trade Messages From Mnuchin, Trump
Stocks end mixed after Treasury Secretary Steven Mnuchin says the U.S. and China were close to reaching a trade agreement, while President Trump hints that he wants to make a trade deal with Beijing but is happy where things are now.